Is pancreatic giant cell tumor resistant to standard chemotherapy?

dc.contributor.authorCaglayan, Dilek
dc.contributor.authorEryilmaz, Melek Karakurt
dc.contributor.authorKorkmaz, Mustafa
dc.contributor.authorKaraagac, Mustafa
dc.contributor.authorHendem, Engin
dc.contributor.authorArtac, Mehmet
dc.date.accessioned2024-02-23T14:21:05Z
dc.date.available2024-02-23T14:21:05Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstractPancreatic giant cell tumors (PGCTs), undifferentiated pancreatic carcinoma are rare tumors of the pancreas. PGCTs consist of osteoclastic, pleomorphic and mixed variants. PGCT is usually diagnosed at an advanced stage. PGCT has a worse prognosis than pancreatic ductal adenocarcinoma. Although surgery can be curative, there is no standard treatment approach for advanced PGCT. We present a case of PGCT that is resistant to standard therapy and progresses in a short time.en_US
dc.identifier.doi10.1097/CAD.0000000000001331
dc.identifier.endpage760en_US
dc.identifier.issn0959-4973
dc.identifier.issn1473-5741
dc.identifier.issue8en_US
dc.identifier.pmid35946539en_US
dc.identifier.scopus2-s2.0-85136848702en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage758en_US
dc.identifier.urihttps://doi.org/10.1097/CAD.0000000000001331
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13443
dc.identifier.volume33en_US
dc.identifier.wosWOS:000841282200007en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofAnti-Cancer Drugsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFolfirinoxen_US
dc.subjectGiant Cell Tumorsen_US
dc.subjectPancreasen_US
dc.subjectResistanten_US
dc.titleIs pancreatic giant cell tumor resistant to standard chemotherapy?en_US
dc.typeArticleen_US

Dosyalar